Applied DNA Sciences (NASDAQ:APDN) Shares to Reverse Split on Thursday, April 25th

Shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) are set to reverse split on the morning of Thursday, April 25th. The 1-20 reverse split was announced on Thursday, April 25th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, April 25th.

Applied DNA Sciences Stock Down 12.1 %

NASDAQ APDN traded down $0.04 during trading on Tuesday, hitting $0.29. The stock had a trading volume of 811,420 shares, compared to its average volume of 116,854. The company has a market capitalization of $4.92 million, a PE ratio of -0.54 and a beta of 0.07. The firm has a 50 day moving average price of $0.49 and a 200 day moving average price of $0.67. Applied DNA Sciences has a twelve month low of $0.28 and a twelve month high of $1.86.

Applied DNA Sciences (NASDAQ:APDN) last released its earnings results on Thursday, February 8th. The technology company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.31) by $0.22. The company had revenue of $0.89 million during the quarter, compared to the consensus estimate of $0.70 million. Applied DNA Sciences had a negative return on equity of 159.93% and a negative net margin of 80.14%. On average, sell-side analysts anticipate that Applied DNA Sciences will post -0.63 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. StockNews.com assumed coverage on Applied DNA Sciences in a research report on Sunday. They issued a “hold” rating for the company. HC Wainwright decreased their price objective on Applied DNA Sciences from $2.00 to $1.50 and set a “buy” rating for the company in a research note on Friday, February 9th.

Hedge Funds Weigh In On Applied DNA Sciences

An institutional investor recently bought a new position in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC bought a new position in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned about 0.72% of Applied DNA Sciences as of its most recent SEC filing. Institutional investors own 22.22% of the company’s stock.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.